Total Payments
$414,908
2023 Payments
$98.45
Companies
18
Transactions
152
Payment Breakdown by Category
Research$250,000 (60.3%)
Consulting$110,603 (26.7%)
Other$30,345 (7.3%)
Travel$20,758 (5.0%)
Food & Beverage$3,203 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $250,000 | 2 | 60.3% |
| Consulting Fee | $110,603 | 24 | 26.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,345 | 10 | 6.1% |
| Travel and Lodging | $20,758 | 56 | 5.0% |
| Honoraria | $5,000 | 1 | 1.2% |
| Food and Beverage | $3,203 | 59 | 0.8% |
Payments by Type
Research
$250,000
2 transactions
General
$164,908
150 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ASSERTIO THERAPEUTICS, INC. | $250,000 | 2 | $0 (2018) |
| Mallinckrodt LLC | $69,698 | 24 | $0 (2021) |
| BTG International, Inc. | $36,385 | 26 | $0 (2021) |
| PFIZER INC. | $27,768 | 17 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $14,294 | 25 | $0 (2017) |
| Wellstat Therapeutics Corporation | $5,000 | 1 | $0 (2018) |
| Cumberland Pharmaceuticals, Inc. | $2,789 | 4 | $0 (2020) |
| Daiichi Sankyo Inc. | $2,173 | 2 | $0 (2018) |
| RARE DISEASE THERAPEUTICS, INC. | $2,120 | 9 | $0 (2023) |
| Purdue Pharma L.P. | $1,905 | 17 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $98.45 | 1 | RARE DISEASE THERAPEUTICS, INC. ($98.45) |
| 2022 | $231.47 | 2 | RARE DISEASE THERAPEUTICS, INC. ($231.47) |
| 2021 | $19,966 | 8 | BTG International, Inc. ($10,675) |
| 2020 | $12,300 | 7 | BTG INTERNATIONAL, INC. ($11,000) |
| 2019 | $64,256 | 47 | Mallinckrodt LLC ($44,855) |
| 2018 | $300,131 | 31 | ASSERTIO THERAPEUTICS, INC. ($250,000) |
| 2017 | $17,926 | 56 | Endo Pharmaceuticals Inc. ($14,294) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2023 | RARE DISEASE THERAPEUTICS, INC. | ANAVIP (Biological) | Food and Beverage | In-kind items and services | $98.45 | General |
| Category: Antivenin | ||||||
| 07/18/2022 | RARE DISEASE THERAPEUTICS, INC. | ANAVIP (Biological) | Food and Beverage | In-kind items and services | $68.90 | General |
| Category: ANTIVENOM | ||||||
| 02/23/2022 | RARE DISEASE THERAPEUTICS, INC. | — | Food and Beverage | In-kind items and services | $162.57 | General |
| 08/27/2021 | RARE DISEASE THERAPEUTICS, INC. | — | Food and Beverage | In-kind items and services | $148.24 | General |
| 07/12/2021 | BTG International, Inc. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,025.00 | General |
| Category: Anti-venom | ||||||
| 06/24/2021 | BTG International, Inc. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,650.00 | General |
| Category: Anti-venom | ||||||
| 05/17/2021 | BTG International, Inc. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Anti-venom | ||||||
| 04/08/2021 | Mallinckrodt LLC | — | Consulting Fee | Cash or cash equivalent | $6,125.00 | General |
| 02/11/2021 | Mallinckrodt LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 02/11/2021 | Mallinckrodt LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 01/26/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: ANTI-VENOM | ||||||
| 11/09/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: ANTI-VENOM | ||||||
| 05/07/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: ANTI-VENOM | ||||||
| 03/05/2020 | RARE DISEASE THERAPEUTICS, INC. | Anavip (Biological) | Food and Beverage | In-kind items and services | $35.19 | General |
| Category: Antivenin | ||||||
| 02/11/2020 | Mallinckrodt LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| 01/29/2020 | Indivior Inc. | — | Food and Beverage | In-kind items and services | $19.95 | General |
| 01/09/2020 | Cumberland Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $744.69 | General |
| 10/25/2019 | PFIZER INC. | LYRICA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $940.00 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/26/2019 | RARE DISEASE THERAPEUTICS, INC. | Anavip (Biological) | Food and Beverage | In-kind items and services | $160.12 | General |
| Category: antivenom | ||||||
| 09/10/2019 | Mallinckrodt LLC | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 08/01/2019 | Purdue Pharma L.P. | ORF (Drug) | Travel and Lodging | Cash or cash equivalent | $79.02 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/01/2019 | Purdue Pharma L.P. | — | Food and Beverage | Cash or cash equivalent | $41.97 | General |
| 07/31/2019 | Purdue Pharma L.P. | ORF (Drug) | Travel and Lodging | Cash or cash equivalent | $176.30 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/31/2019 | Purdue Pharma L.P. | ORF (Drug) | Travel and Lodging | Cash or cash equivalent | $166.75 | General |
| Category: PAIN MANAGEMENT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RADARS System | ASSERTIO THERAPEUTICS, INC. | $250,000 | 2 |
About Dr. Richard Dart, MD
Dr. Richard Dart, MD is a Medical Toxicology healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528082492.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Dart, MD has received a total of $414,908 in payments from pharmaceutical and medical device companies, with $98.45 received in 2023. These payments were reported across 152 transactions from 18 companies. The most common payment nature is "" ($250,000).
Ad
Practice Information
- Specialty Medical Toxicology
- Location Aurora, CO
- Active Since 07/26/2006
- Last Updated 02/01/2011
- Taxonomy Code 207PT0002X
- Entity Type Individual
- NPI Number 1528082492
Products in Payments
- Nucynta (Drug) $250,000
- CROFAB (Drug) $36,385
- LYRICA (Drug) $24,585
- OPANA (Drug) $14,232
- VISTOGARD (Drug) $5,000
- EMBEDA (Drug) $1,900
- ORF (Drug) $1,720
- Anavip (Biological) $1,641
- CL-108 (Drug) $1,473
- LIPITOR (Drug) $1,091
- CFN Pyxis (Device) $786.67
- ANAVIP (Biological) $167.35
- XTAMPZA ER (Drug) $137.50
- ZOHYDRO ER (Drug) $125.62
- Nucynta ER (Drug) $124.96
- Xtampza ER (Drug) $106.31
- XTAMPZA (Drug) $92.36
- OPANA ER (Drug) $62.05
- ARYMO ER (Drug) $36.28
- XARELTO (Drug) $17.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.